Kathryn R. Starr

773 citations

16 papers · 476 indexed · h-index 13

Biological Psychiatry top 10%
Cellular and Molecular Neuroscience top 10%
- Neurotransmitter Receptor Influence on Behavior 10
- Neuroscience and Neuropharmacology Research 6
Endocrine and Autonomic Systems top 10%
Behavioral Neuroscience top 10%
- Stress Responses and Cortisol 2
Pharmacology top 10%
Molecular Biology
- Receptor Mechanisms and Signaling 8
- Ion channel regulation and function 2
Social Psychology
- Neuroendocrine regulation and behavior 2
Endocrinology, Diabetes and Metabolism
- Pituitary Gland Disorders and Treatments 1
Experimental and Cognitive Psychology
- Sleep and related disorders 1

Co-authors: Lee A. Dawson Mark Duxon Zoë A. Hughes J.J. Hagan N. Upton Declan N.C. Jones Christopher J. Langmead Gerd D. Bartoszyk
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Endocrine and Autonomic Systems
Journals: Brain Research (2 papers)Journal of Medicinal Chemistry (1 paper)British Journal of Pharmacology (2 papers)
Partner nations: United Kingdom Italy Netherlands

In The Last Decade

Kathryn R. Starr

16 papers receiving 460 citations

Peers

Countries citing papers authored by Kathryn R. Starr

Since Specialization

Citations

This map shows the geographic impact of Kathryn R. Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn R. Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn R. Starr more than expected).

Fields of papers citing papers by Kathryn R. Starr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn R. Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn R. Starr. The network helps show where Kathryn R. Starr may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kathryn R. Starr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathryn R. Starr Line = papers co-authored together Kathryn R. Starr links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	Pharmacological characterisation of MDI-222, a novel AMPA receptor positive allosteric modulator with an improved safety profile Journal of Psychopharmacology ·Simon E. Ward,Mark H Harries,Laura Aldegheri,Andrea M. Bradford,Elisa Ballini,Lee A. Dawson,Laurent Lacroix,Joanne Pardoe,Kathryn R. Starr,Annette Weil,Kerry A. Waters,John Atack,Marie L. Woolley	2019	14
2	Pharmacological characterization ofN‐[(2S)‐5‐(6‐fluoro‐3‐pyridinyl)‐2, 3‐dihydro‐1H‐inden‐2‐yl]‐2‐propanesulfonamide: a novel, clinical AMPA receptor positive allosteric modulator British Journal of Pharmacology ·Simon E. Ward,Paul Beswick,Novella Calcinaghi,Lee A. Dawson,Jane Gartlon,Francesca Graziani,Declan N.C. Jones,Laurent Lacroix,M. H. Selina Mok,Beatrice Oliosi,Joanne Pardoe,Kathryn R. Starr,Marie L. Woolley,Mark H Harries	2016	12
3	Glycine transporter 1 (GlyT1) inhibitors exhibit anticonvulsant properties in the rat maximal electroshock threshold (MEST) test Brain Research ·Mikhail Kalinichev,Kathryn R. Starr,Simon J. Teague,Andrea M. Bradford,Rod A. Porter,Hugh J. Herdon	2010	16
4	Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory activity Bioorganic & Medicinal Chemistry Letters ·Halina T. Serafinowska,Frank E. Blaney,Peter J. Lovell,Giancarlo Merlo,Claire M. Scott,Paul W. Smith,Kathryn R. Starr,Jeannette M. Watson	2008	18
5	Discovery of Potent, Orally Bioavailable, Selective 5-HT_1A/B/D Receptor Antagonists Journal of Medicinal Chemistry ·Simon E. Ward,Peter Eddershaw,Claire M. Scott,Laurie Gordon,Peter J. Lovell,Susan H. Moore,Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Jeannette M. Watson	2008	9
6	Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia Brain Research ·Melanie J. Robbins,Kathryn R. Starr,Andy Honey,Ellen M. Soffin,Claire Rourke,Gareth Jones,F. M. Kelly,Jay C. Strum,Rosemary A. Melarange,Andy J. Harris,Magalie Rocheville,T. Rupniak,Paul R. Murdock,Declan N.C. Jones,James N.C. Kew,Peter R. Maycox	2007	48
7	Simultaneous blockade of 5-HT1A/B receptors and 5-HT transporters results in acute increases in extracellular 5-HT in both rats and guinea pigs: in vivo characterization of the novel 5-HT1A/B receptor antagonist/5-HT transport inhibitor SB-649915-B Psychopharmacology ·Zoë A. Hughes,Kathryn R. Starr,Claire M. Scott,Michael Newson,Trevor Sharp,Jeannette M. Watson,Jim J. Hagan,Lee A. Dawson	2007	23
8	SB-649915-B, a Novel 5-HT1A/B Autoreceptor Antagonist and Serotonin Reuptake Inhibitor, is Anxiolytic and Displays Fast Onset Activity in the Rat High Light Social Interaction Test Neuropsychopharmacology ·Kathryn R. Starr,Gary Price,Jeannette M. Watson,Peter J. Atkinson,Roberto Arban,Sergio Melotto,Lee A. Dawson,Jim J. Hagan,Neil Upton,Mark Duxon	2007	43
9	3,4-Dihydro-2H-benzoxazinones as dual-acting 5-HT1A receptor antagonists and serotonin reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Peter J. Lovell,Frank E. Blaney,Caroline J. Goodacre,Claire M. Scott,Paul W. Smith,Kathryn R. Starr,Kevin M. Thewlis,Antonio Vong,Simon E. Ward,Jeannette M. Watson	2006	13
10	SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′methyl-4′-(5-methyl-1,2,3-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): A novel, potent and selective 5-HT1B receptor antagonist Neuropharmacology ·Claire M. Scott,Christopher J. Langmead,Kirsten L. Clarke,Paul Wyman,Paul W. Smith,Kathryn R. Starr,Lee A. Dawson,Gary Price,J.J. Hagan,Jeannette M. Watson	2006	5
11	Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2′-methyl-4′-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): In vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity Neuropharmacology ·Lee A. Dawson,Zoë A. Hughes,Kathryn R. Starr,James D. Storey,Letizia Bettelini,Fabrizio Bacchi,Roberto Arban,Alessandro Poffe,Sergio Melotto,J.J. Hagan,Gary Price	2006	32
12	Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data Psychopharmacology ·Claire Rourke,Kathryn R. Starr,Charlie Reavill,Sue Fenwick,Kim Deadman,Declan N.C. Jones	2005	18
13	A series of bisaryl imidazolidin-2-ones has shown to be selective and orally active 5-HT2C receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Caroline J. Goodacre,Steven M. Bromidge,David Clapham,Frank D. King,Peter J. Lovell,Mike Allen,Lorraine Campbell,Vicky Holland,Graham J. Riley,Kathryn R. Starr,Brenda Trail,Martyn Wood	2005	14
14	Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone European Journal of Pharmacology ·Zoë A. Hughes,Kathryn R. Starr,Christopher J. Langmead,Matthew Hill,Gerd D. Bartoszyk,J.J. Hagan,Derek N. Middlemiss,Lee A. Dawson	2005	94
15	Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement Psychopharmacology ·Mark Duxon,Jennifer L. Stretton,Kathryn R. Starr,Declan N.C. Jones,Vicky Holland,Graham J. Riley,Jeff Jerman,Stephen Brough,Darren Smart,Amanda Johns,Wai N. Chan,Rod A. Porter,Neil Upton	2001	79
16	Latency to paroxetine‐induced anxiolysis in the rat is reduced by co‐administration of the 5‐HT_1A receptor antagonist WAY100635 British Journal of Pharmacology ·Mark Duxon,Kathryn R. Starr,N. Upton	2000	38

About Kathryn R. Starr

Kathryn R. Starr is a scholar working on Cellular and Molecular Neuroscience, Behavioral Neuroscience and Biological Psychiatry, having authored 16 papers that have together received 476 indexed citations. Recurring topics across this work include Neurotransmitter Receptor Influence on Behavior (10 papers), Receptor Mechanisms and Signaling (8 papers), Neuroscience and Neuropharmacology Research (6 papers), Stress Responses and Cortisol (2 papers), Ion channel regulation and function (2 papers), Neuroendocrine regulation and behavior (2 papers), Pituitary Gland Disorders and Treatments (1 paper) and Sleep and related disorders (1 paper). The work is most often cited by research in Biological Psychiatry (54 citations), Cellular and Molecular Neuroscience (246 citations) and Endocrine and Autonomic Systems (77 citations). Kathryn R. Starr has collaborated with scholars based in United Kingdom, Italy and Netherlands. Frequent co-authors include Lee A. Dawson, Mark Duxon, Zoë A. Hughes, J.J. Hagan, N. Upton, Declan N.C. Jones, Christopher J. Langmead, Gerd D. Bartoszyk, Jeannette M. Watson and Derek N. Middlemiss. Their work appears in journals such as Brain Research, Journal of Medicinal Chemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact